•  
  •  
  •  
  •  

2026-08-17 13:32:07

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Enviro Infra Engineers Reports 49.1% Revenue Growth to ₹ 3,592 Million in Q1 FY27; PAT Rises 6.5% to ₹ 452 Million
  • Wanbury Limited Reports Q1 FY27 Revenue of ₹165.6 Crore; Refinances ₹205 Crore Debt to Cut Interest Costs
  • Popular Vehicles & Services Reports 44.6% YoY Revenue Growth to ₹1,903.1 Crore in Q1 FY27; Turns Profitable with ₹1.4 Crore PAT
  • Hirect Limited Reports 20.3% Revenue Growth in Q1 FY27; Standalone Net Profit Up 17.8% Amid Global Expansion
  • Delton Cables reports highest ever first quarterly Revenue, EBITDA & PAT

Keywords Selected:  ACE

Research

  • Crisil Ratings : Data centre operators' revenue to surge 20-22% annually till fiscal 2028
  • CRISIL: Pharmaceutical sector set for 8-10% revenue growth this fiscal
  • Elara Securities India - Diet Report - Ambuja Cements - Cash deployment starts
  • Kotak Institutional Equities - Pharmaceuticals: IPM pulse - gaining momentum
  • Payback period for investment in sustainable warehouses come down to three years in India: A JLL - IndoSpace report
  • CRISIL Ratings: Mall area to rise by 35% over the medium term on retail surge
  • CRISIL Ratings: Higher workplace occupancy to light up cigarette volume 7-9%
  • Company Update - P&G Health - ICICI Direct
  • Profits on Housing Investment - Past, Present, and Future
  • Coworking Share in Office Real Estate at 20% in H1 2022 from 6% in 2021
  • Over 45 Data Centres Spanning ~13 Mn Sft to Boot Up in India by 2025-end
  • Why Commercial Real Estate Investors are betting on Office Spaces
  • ICRA's sample set of Indian pharmaceutical companies to grow by 6-7% in FY2023: ICRA
  • Initiating Coverage - Hindustan Aeronautics Ltd - ICICI Direct
  • UltraTech Cement - Cost escalations getting passed on QoQ - ICICI Securities
  • Ambuja Cements - 1QCY22 Result Update - Realization Falters, but Volume and EBITDA Beat
  • Ambuja Cement - Cost controls lift margin QoQ - HDFC Securities
  • Company Update - Mahindra Lifespace Developers - ICICI Direct
  • Ambuja Cements - Improved margins over sequential cost decline - YES Securities
  • Ambuja Cement - Q1CY22 Result Update - Beat on estimates; Clarity on Holcim's exit holds the key - Downgrade to 'HOLD'
  • Mahindra Lifespaces - Outperformance continues - HDFC Securities
  • Mahindra Lifespace Developers - Well poised for growth - ICICI Securities
  • Ambuja Cement - Q1CY22 First Cut - ICICI Direct
  • Ambuja Cements - 4QCY21 Result Update - Cost Pressure Led to EBITDA Miss

IPO News

  • SBI Funds, DSP India Fund, Think India Opportunities Fund invest Rs. 144 cr in Aequs Ltd. in pre-IPO placement deal
  • Accretion Pharmaceuticals' IPO Opens for subscription today, Price Band set at ₹96-101 per Share
  • Accretion Pharmaceuticals Ltd IPO to open for subscription on May 14, 2025
  • Senores Pharmaceuticals IPO subscribed 13.93 times on Day 2
  • Senores Pharmaceuticals IPO fully subscribed on Day 1
  • Senores Pharmaceuticals gets Sebi nod for IPO
  • IT Solutions major, Rashi Peripherals raised Rs 150 crore in Pre-IPO round
  • Awfis Space Solutions Limited files DRHP with SEBI
  • Jupiter Life Line Hospitals raised Rs123 cr in pre -IPO round
  • Penna Cement gets Sebi nod for Rs 1,550 crore IPO

Stock Report

  • Wanbury Limited Reports Q1 FY27 Revenue of ₹165.6 Crore; Refinances ₹205 Crore Debt to Cut Interest Costs
  • Innova Captab Limited reported strong results for Q1 FY27, with Revenue from Operations at ₹ 470.9 crores and EBITDA at ₹ 75.1 crores
  • Viyash Scientific Delivers Strong Q1 FY27 Performance: PAT Surges 114.9% to ₹793 Million
  • Varenyam Biolifesciences to upgrade its upcoming Savli facility to offer biologics and biosimilar CDMO services for US, EU and SRA RoW markets
  • Fermenta Q1FY27 Consolidated Revenue INR 126.2 crore; flat QoQ and down 13% YoY
  • Zydus Lifesciences Reports Q1 FY27 Results: Operational Revenue Up 22% to ₹80,170 Million
  • AstraZeneca Pharma India Starts FY2026-27 with 30% Operational Revenue Growth Driven by Core Therapies
  • Adani Cement Industries Ltd commissions 1.2 MTPA brownfield expansion project
  • Jubilant Pharmova Reports 17% YoY Revenue Growth to ₹2,229 Crore in Q1 FY27; CDMO Sterile Injectables Surges 34%
  • Wockhardt Antibiotic Academy, an initiative for Patient - Centric Scientific Dialogue to Tackle Multidrug Resistance
  • Lupin Announces the Approval of Sodium Zirconium Cyclosilicate for Oral Suspension in the United States
  • IOL Chemicals and Pharmaceuticals Delivers Strong Q1 FY27 Results with 89.9% YoY PAT Surge to ₹64.5 Crore
  • Zydus launches REVAHALE™, India's first once-daily nebulised LAMA for COPD
  • Lyka Labs Reports Q1 FY27 Financial Results; Consolidated Net Profit Surges 105.4% YoY
  • Mahindra Group Announces Dedicated Strategic Focus on Holidays and Lifespaces Sector to Accelerate Growth
  • Gland Pharma Announces Strategic CDMO Partnership with a Global Pharmaceutical Company
  • Blue Jet Healthcare Reports Q1 FY27 Results: Net Profit Reaches ₹78.26 Crore; Revenue Up 24.9% QoQ
  • GPCB Revokes Closure Notice for Aarti Drugs' Sayakha Plant; Operations Resume Following EDC Payment
  • Zydus Lifesciences Ltd receives EIR from the USFDA for its injectable facility with VAI classification
  • Zodiac Energy Ltd receives PO for domestic order
  • Divi's Laboratories Reports Strong Q1 FY27 Results: Consolidated PAT Soars 65% YoY to ₹902 Crore
  • Aarti Drugs Limited Announces Leadership Transition to Strengthen Governance and Ensure Long-Term Strategic Growth
  • Glenmark Pharmaceuticals Announces Q1 FY27 Results
  • Lupin Announces the Approval of Diazepam Injection, USP in the United States

Industry News

  • Mindspace EcoRun 2.0 Returns for Second Year
  • Amansa Investment invests Rs 40 crore private placement in IPO bound Standard Glass Lining Technology
  • Millennium Babycares Ltd raises INR 1220 Million in Private Placement Round from Bharat Value Fund
  • VIKRAN Engineering Closes Pre-IPO Up-round of INR 100 Crores
  • Awfis expands in Bhubaneshwar with almost 1L sq ft space
  • Uber India is now Great Place To Work Certified
  • The Leela Palaces, Hotels and Resorts wins Best Hotel Group in India
  • The Leela Palaces, Hotels and Resorts announces its foray into Northeast India
  • NYSE Listed Amneal Pharmaceuticals begins Commercial Operations in India
  • As Offices are Reopening, Investing in commercial assets might be a lucrative deal
  • Want to save Construction cost? Follow these seven tips
  • SIDBI joins hands with UPEIDA to support MSMEs in Aerospace & Defence sector

Latest Post

  • Enviro Infra Engineers Reports 49.1% Revenue Growth to ₹ 3,592 Million in Q1 FY27; PAT Rises 6.5% to ₹ 452 Million
  • Wanbury Limited Reports Q1 FY27 Revenue of ₹165.6 Crore; Refinances ₹205 Crore Debt to Cut Interest Costs
  • Popular Vehicles & Services Reports 44.6% YoY Revenue Growth to ₹1,903.1 Crore in Q1 FY27; Turns Profitable with ₹1.4 Crore PAT
  • Hirect Limited Reports 20.3% Revenue Growth in Q1 FY27; Standalone Net Profit Up 17.8% Amid Global Expansion
  • Delton Cables reports highest ever first quarterly Revenue, EBITDA & PAT


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025